Work

Ibrutinib Is Effective in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Results from a Prospective Phase II Study

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-115476

Authors: Solomon A. Graf, Ryan D. Cassaday, Karolyn K. Morris, Heather A. Rasmussen, Pamela S. Becker, Thomas R. Chauncey, Sandra Kanan, Lorinda A. Soma, Stephen D. Smith, Ajay K. Gopal

Institutions: University of Washington, Fred Hutch Cancer Center, Seattle Cancer Care Alliance

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2911428551

Cites:

Cited by: 1

Related to: 10